Monitoring the Inhalation Flow Rate of Nebulized Aerosols Using an Ultrasonic Flow Meter: In Vitro Assessment.

BACKGROUND: The measurement of aerosol flow rates without obscuration of the flow is of particular concern with in vivo lung deposition studies, where precise knowledge of aerosol particle size distributions is a necessary requirement for the development of predictive correlations. This study examines the utility of an ultrasonic flow meter for such measurements and determines if a valved system can be attached to the flow meter for sampling exhaled aerosols. METHODS: The flow rate across a D-30 flow meter was compared with and without nebulization of 0.9% saline aerosols from a PARI LC Sprint nebulizer. Particle size distributions of the nebulized aerosol before and after adding the D-30 flow meter and duckbill valve were measured using a Spraytec laser diffraction system. Finally, the ability of the Thor D-30 to capture a realistic breathing profile was assessed. RESULTS: The mean ± standard error flow rates measured by the D-30 flow meter with and without nebulization were 10.4 ± 0.1 versus 10.4 ± 0.1 L/min, 66.4 ± 0.1 versus 67.2 ± 0.1 L/min, and 89.9 ± 0.1 versus 91.4 ± 0.1 L/min. The D-30 flow meter did not considerably affect the volumetric median diameter (VMD) of the aerosols, while the VMD reduced slightly by 0.65 µm at 10 L/min and 0.69 µm at 72 L/min upon the inclusion of a duckbill valve. Time-weighted average inhalation flow rates measured by D-30 flow meters placed upstream and downstream of the one-way valve agreed well, 31.9 versus 32.6 L/min, respectively. CONCLUSIONS: The D-30 flow meter can be used to accurately measure inhalation flow rates of nebulized aerosols without significantly impacting particle size distributions, and one-way duckbill valves can be used to isolate the inhalation portion of a breathing pattern to facilitate collection of exhaled doses.

The effect of device resistance and inhalation flow rate on the lung deposition of orally inhaled mannitol dry powder.

The present study investigates the effect of DPI resistance and inhalation flow rates on the lung deposition of orally inhaled mannitol dry powder. Mannitol powder radiolabeled with 99mTc-DTPA was inhaled from an Osmohaler™ by healthy human volunteers at 50-70L/min peak inhalation flow rate (PIFR) using both a low and high resistance Osmohaler™, and 110-130L/min PIFR using the low resistance Osmohaler™ (n=9). At 50-70L/min PIFR, the resistance of the Osmohaler™ did not significantly affect the total and peripheral lung deposition of inhaled mannitol [for low resistance Osmohaler™, 20% total lung deposition (TLD), 0.3 penetration index (PI); for high resistance Osmohaler™, 17% TLD, 0.23 PI]. Increasing the PIFR 50-70L/min to 110-130L/min (low resistance Osmohaler™) significantly reduced the total lung deposition (10% TLD) and the peripheral lung deposition (PI 0.21). The total lung deposition showed dependency on the in vitro FPF (R2=1.0). On the other hand, the PI had a stronger association with the MMAD (R2=1.0) than the FPF (R2=0.7). In conclusion the resistance of Osmohaler™ did not significantly affect the total and regional lung deposition at 50-70L/min PIFR. Instead, the total and regional lung depositions are dependent on the particle size of the aerosol and inhalation flow rate, the latter itself affecting the particle size distribution.